XW
Healthcare & Life Sciences
XWPharma
China
XWPharma is a Healthcare & Life Sciences startup based in China, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About XWPharma
Based in China, XWPharma is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
XWPharma is a Wuhan-based biopharmaceutical company focused on discovering and developing therapeutics for neurological and psychiatric disorders, with its lead program being a Phase 2 oral NMDA antagonist for treatment-resistant depression.
Explore XWPharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.